MRC

MUPIROCIN

Created:	1999-07-08
Last modified:	2023-08-14

Find Related PDB Entry
7 entries where MRC is found as a standalone ligand

Help Find related ligands:
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Help

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	79
Chiral Atom Count	8
Bond Count	80
Aromatic Bond Count	0

WebGL does not seem to be available.

This can be caused by an outdated browser, graphics card driver issue, or bad weather. Sometimes, just restarting the browser helps. Also, make sure hardware acceleration is enabled in your browser.

For a list of supported browsers, refer to http://caniuse.com/#feat=webgl.

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	MUPIROCIN
Synonyms	9-[(E)-4-[(2S,3R,4R,5S)-3,4-bis(oxidanyl)-5-[[(2S,3S)-3-[(2S,3S)-3-oxidanylbutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methyl-but-2-enoyl]oxynonanoic acid; PSEUDOMONIC ACID
Systematic Name (OpenEye OEToolkits)	9-[(~{E})-4-[(2~{S},3~{R},4~{R},5~{S})-3,4-bis(oxidanyl)-5-[[(2~{S},3~{S})-3-[(2~{S},3~{S})-3-oxidanylbutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methyl-but-2-enoyl]oxynonanoic acid
Formula	C₂₆ H₄₄ O₉
Molecular Weight	500.622
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	C[CH](O)[CH](C)[CH]1O[CH]1C[CH]2CO[CH](CC(C)=CC(=O)OCCCCCCCCC(O)=O)[CH](O)[CH]2O
SMILES	OpenEye OEToolkits	2.0.7	CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O
Canonical SMILES	CACTVS	3.385	C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]2CO[C@@H](C/C(C)=C/C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]2O
Canonical SMILES	OpenEye OEToolkits	2.0.7	C[C@H]([C@H]1[C@@H](O1)C[C@H]2CO[C@H]([C@@H]([C@@H]2O)O)C/C(=C/C(=O)OCCCCCCCCC(=O)O)/C)[C@H](C)O
InChI	InChI	1.06	InChI=1S/C26H44O9/c1-16(13-23(30)33-11-9-7-5-4-6-8-10-22(28)29)12-20-25(32)24(31)19(15-34-20)14-21-26(35-21)17(2)18(3)27/h13,17-21,24-27,31-32H,4-12,14-15H2,1-3H3,(H,28,29)/b16-13+/t17-,18-,19-,20-,21-,24+,25-,26-/m0/s1
InChIKey	InChI	1.06	MINDHVHHQZYEEK-HBBNESRFSA-N

Drug Info: DrugBank

DrugBank ID	DB00410
Name	Mupirocin
Groups	vet_approved approved investigational
Description	Mupirocin, formerly termed pseudomonic acid A,[A178531] is a novel antibacterial agent with a unique chemical structure and mode of action apart from other antibiotic agents. Produced by fermentation using the organism _Pseudomonas fluorescens_, mupirocin is a naturally-occurring antibiotic that displays a broad-specturm activity against many gram-positive bacteria and certain gram-negative bacteria _in vitro_.[L10580] It primarily works by inhibiting bacterial protein synthesis. Due to its unique mode of action of inhibiting the activity of bacterial isoleucyl-tRNA synthetase, mupirocin does not demonstrate cross-resistance with other classes of antimicrobial agents, giving it a therapeutic advantage.[L10580] It is available in topical formulations only due to extensive systemic metabolism[A178531] and is used in the treatment of impetigo caused by _Staphylococcus aureus_ and _Streptococcus pyogenes_ and traumatic skin lesions due to secondary skin infections caused by _S. aureus_ and _S. pyogenes_. There is also some clinical evidence that suggests the potential role of mupirocin in eradicating nasal carriage of Staphylococci when administered intranasally.[A178531,A178591] Mupirocin is commonly marketed under the brand name Bactroban.
Synonyms	Mupirocinum Pseudomonic acid 9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3- [(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl] oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid Mupirocin Mupirocine Mupirocina Mupirocin calcium Pseudomonic acid A
Brand Names	WhyteDerm SurgiPak PS2 Aciurgy Pack Centany DermacinRx Surgical PharmaPak NuSurgePak Surgical Prep/CarePak Stramucin Dermawerx Surgical Plus Pak Pirnuo Centany AT Pre and Post Sx Pouch Mupirocin Powder Metronidazole 1% / Mupirocin 2% / Levocetirizine Dihydrochloride 2% / Mupirocin 2% / Triamcinolone Acetonide 0.025% Bactroban Nasal Ointment PS1 Aciurgy Pack DermacinRx Clorhexacin Lidocaine 2% / Mupirocin 2% Metronidazole 1% / Mupirocin 2% Taro-mupirocin Bactroban Mupirocin 2% Bactroban Cream Mupirocin Mupirocin Calcium
Indication	Indicated for the treatment of impetigo and secondary skin infections, leading to traumatic skin lesions, due to _Staphylococcus aureus_ and _Streptococcus pyogenes_.[L10580]
Categories	Anti-Bacterial Agents Anti-Infective Agents Antibiotics for Topical Use Dermatologicals Enzyme Inhibitors Epoxy Compounds Ethers Ethers, Cyclic Fatty Acids Lipids Nasal Preparations Protein Synthesis Inhibitors Pyrans RNA Synthetase Inhibitor Antibacterial RNA Synthetase Inhibitors
ATC-Code	R01AX06 D06AX09
CAS number	12650-69-0

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Isoleucine--tRNA ligase	MDYKETLLMPKTDFPMRGGLPNKEPQIQEKWDAEDQYHKALEKNKGNETF...	unknown	inhibitor

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682